pubmed-article:1752778 | rdf:type | pubmed:Citation | lld:pubmed |
pubmed-article:1752778 | lifeskim:mentions | umls-concept:C0006142 | lld:lifeskim |
pubmed-article:1752778 | lifeskim:mentions | umls-concept:C0086418 | lld:lifeskim |
pubmed-article:1752778 | lifeskim:mentions | umls-concept:C0025932 | lld:lifeskim |
pubmed-article:1752778 | lifeskim:mentions | umls-concept:C0332835 | lld:lifeskim |
pubmed-article:1752778 | lifeskim:mentions | umls-concept:C0014939 | lld:lifeskim |
pubmed-article:1752778 | lifeskim:mentions | umls-concept:C0019932 | lld:lifeskim |
pubmed-article:1752778 | lifeskim:mentions | umls-concept:C0202220 | lld:lifeskim |
pubmed-article:1752778 | lifeskim:mentions | umls-concept:C1280500 | lld:lifeskim |
pubmed-article:1752778 | lifeskim:mentions | umls-concept:C0598934 | lld:lifeskim |
pubmed-article:1752778 | pubmed:issue | 11 | lld:pubmed |
pubmed-article:1752778 | pubmed:dateCreated | 1992-1-24 | lld:pubmed |
pubmed-article:1752778 | pubmed:abstractText | The effects of estrogens and tamoxifen were analyzed on estrogen receptor-positive human breast cancer (MCF-7) transplanted into athymic nude mice. It was found that (1) the tumor growth and the proportion of 3H-thymidine-labeled cells were significantly increased in the 17 beta-estradiol dipropionate (E2) group, but significantly decreased in the tamoxifen (TAM) group with respect to the control group, and (2) the tumor content of insulin-like growth factor-1 (IGF-1) and the rate of IGF-1-positive cells were significantly lower in the E2 group, but significantly higher in the TAM group than in the control group. It was concluded that the tumor content of IGF-1 and the proportion of IGF-I-positive cells were inversely correlated to the tumor growth and the 3H-thymidine labeling index in vivo. | lld:pubmed |
pubmed-article:1752778 | pubmed:language | eng | lld:pubmed |
pubmed-article:1752778 | pubmed:journal | http://linkedlifedata.com/r... | lld:pubmed |
pubmed-article:1752778 | pubmed:citationSubset | IM | lld:pubmed |
pubmed-article:1752778 | pubmed:chemical | http://linkedlifedata.com/r... | lld:pubmed |
pubmed-article:1752778 | pubmed:chemical | http://linkedlifedata.com/r... | lld:pubmed |
pubmed-article:1752778 | pubmed:chemical | http://linkedlifedata.com/r... | lld:pubmed |
pubmed-article:1752778 | pubmed:chemical | http://linkedlifedata.com/r... | lld:pubmed |
pubmed-article:1752778 | pubmed:chemical | http://linkedlifedata.com/r... | lld:pubmed |
pubmed-article:1752778 | pubmed:status | MEDLINE | lld:pubmed |
pubmed-article:1752778 | pubmed:month | Nov | lld:pubmed |
pubmed-article:1752778 | pubmed:issn | 0910-5050 | lld:pubmed |
pubmed-article:1752778 | pubmed:author | pubmed-author:NoguchiMM | lld:pubmed |
pubmed-article:1752778 | pubmed:author | pubmed-author:MiyazakiII | lld:pubmed |
pubmed-article:1752778 | pubmed:author | pubmed-author:MizukamiYY | lld:pubmed |
pubmed-article:1752778 | pubmed:author | pubmed-author:KoyasakiNN | lld:pubmed |
pubmed-article:1752778 | pubmed:issnType | Print | lld:pubmed |
pubmed-article:1752778 | pubmed:volume | 82 | lld:pubmed |
pubmed-article:1752778 | pubmed:owner | NLM | lld:pubmed |
pubmed-article:1752778 | pubmed:authorsComplete | Y | lld:pubmed |
pubmed-article:1752778 | pubmed:pagination | 1199-202 | lld:pubmed |
pubmed-article:1752778 | pubmed:dateRevised | 2004-11-17 | lld:pubmed |
pubmed-article:1752778 | pubmed:meshHeading | pubmed-meshheading:1752778-... | lld:pubmed |
pubmed-article:1752778 | pubmed:meshHeading | pubmed-meshheading:1752778-... | lld:pubmed |
pubmed-article:1752778 | pubmed:meshHeading | pubmed-meshheading:1752778-... | lld:pubmed |
pubmed-article:1752778 | pubmed:meshHeading | pubmed-meshheading:1752778-... | lld:pubmed |
pubmed-article:1752778 | pubmed:meshHeading | pubmed-meshheading:1752778-... | lld:pubmed |
pubmed-article:1752778 | pubmed:meshHeading | pubmed-meshheading:1752778-... | lld:pubmed |
pubmed-article:1752778 | pubmed:meshHeading | pubmed-meshheading:1752778-... | lld:pubmed |
pubmed-article:1752778 | pubmed:meshHeading | pubmed-meshheading:1752778-... | lld:pubmed |
pubmed-article:1752778 | pubmed:meshHeading | pubmed-meshheading:1752778-... | lld:pubmed |
pubmed-article:1752778 | pubmed:meshHeading | pubmed-meshheading:1752778-... | lld:pubmed |
pubmed-article:1752778 | pubmed:meshHeading | pubmed-meshheading:1752778-... | lld:pubmed |
pubmed-article:1752778 | pubmed:meshHeading | pubmed-meshheading:1752778-... | lld:pubmed |
pubmed-article:1752778 | pubmed:meshHeading | pubmed-meshheading:1752778-... | lld:pubmed |
pubmed-article:1752778 | pubmed:meshHeading | pubmed-meshheading:1752778-... | lld:pubmed |
pubmed-article:1752778 | pubmed:meshHeading | pubmed-meshheading:1752778-... | lld:pubmed |
pubmed-article:1752778 | pubmed:meshHeading | pubmed-meshheading:1752778-... | lld:pubmed |
pubmed-article:1752778 | pubmed:meshHeading | pubmed-meshheading:1752778-... | lld:pubmed |
pubmed-article:1752778 | pubmed:year | 1991 | lld:pubmed |
pubmed-article:1752778 | pubmed:articleTitle | Effects of hormones on tumor growth and immunoreactive insulin-like growth factor-1 of estrogen receptor-positive human breast cancer (MCF-7) transplanted in nude mice. | lld:pubmed |
pubmed-article:1752778 | pubmed:affiliation | Operation Center, Kanazawa University Hospital. | lld:pubmed |
pubmed-article:1752778 | pubmed:publicationType | Journal Article | lld:pubmed |